These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11338682)

  • 1. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
    Fukuda M; Endo K; Takinami S; Kawai N; Tominaga K; Maesaki S; Bessho M; Yamazaki T
    Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    Fukuda M; Kobayashi Y; Endo K; Kawai N; Tominaga K; Bessho M; Hirashima K
    Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
    Urabe A; Fujita A; Aoki K; Koike M; Kitamura K; Ohbayashi Y; Oshimi K; Wakabayashi Y; Kuraishi Y; Kurihara I; Togawa A; Hoshino S; Ozawa K; Hotta T; Higashihara M; Nagoshi H; Hirai H; Omine M; Asano S; Nishimura M; Suzuki K; Bessho M; Mizoguchi H; Furusawa S; Nonaka Y; Takaku F
    Jpn J Antibiot; 2000 Feb; 53(2):61-74. PubMed ID: 10786314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
    Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
    Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of neutropenic fever associated with hematological disorders].
    Fukuda M; Endo K; Ito K; Kawai N; Tominaga K; Bessho M; Hirasima K
    Kansenshogaku Zasshi; 2001 Mar; 75(3):186-92. PubMed ID: 11321778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
    Yamane T; Tanaka K; Hasuike T; Hirai M; Misu K; Ota K; Ohira H; Nakao Y; Yasui Y; Inoue T
    Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of cefpirome sulfate for severe infections in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infections].
    Hamazaki H; Hasegawa H; Horiuchi A; Teshima H; Hiraoka A; Masaoka T; Nasu K; Uchino H; Tatsumi N; Inoue N; Kageyama T; Kawagoe H; Tukaguchi M; Hukuhara S; Takahashi T; Takatsuka H; Kanamaru A; Kakishita E; Nagai K; Hara H; Kanayama Y; Sugiyama H; Kitani T
    Jpn J Antibiot; 1997 Jan; 50(1):12-21. PubMed ID: 9059910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of cefozopran as treatment for febrile neutropenia].
    Saito T; Hara M; Shinagawa K; Nawa Y; Nakase K; Takeuchi M; Miyata A; Fukuda S; Sunami K; Imajoh K; Yano T; Kojima K; Teshima T; Fujii N; Ishimaru F; Ikeda K; Harada M; Tanimoto M
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):61-5. PubMed ID: 14750323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
    Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
    Hirakawa K; Tsuda S; Misawa S; Ueda Y; Kaneko H; Nakao M; Ariyama Y; Nakai H; Seriu T; Takashima T
    Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
    Toyama K; Yaguchi M; Uchida Y; Suzuki K; Sawanobori M; Ikeda Y; Matsuoka S; Wakasugi K; Furuya T; Oshimi K; Kawamata N; Kikuchi M; Murakami H; Tsuruoka N; Tomoyasu S; Kawaguchi M; Hirosawa S; Yamamoto K; Shirota T; Harada Y; Dan K; Yamada T; Kawano K; Onozawa Y; Takeuchi J
    Jpn J Antibiot; 1999 Feb; 52(2):153-61. PubMed ID: 10221180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders].
    Kitamura K; Miyagawa K; Urabe A; Sato H; Obayashi Y; Aoki I; Takaku F; Togawa A; Shindou E; Wakabayashi Y; Ohshima T; Horikoshi A; Nomura T; Ohki I; Suzuki K; Kamakura M; Oguchi A; Toyama K; Yaguchi M; Aoki N; Kato A; Mizoguchi H; Masuda M; Irie S; Fujioka S
    Jpn J Antibiot; 1996 Dec; 49(12):1062-72. PubMed ID: 9032593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
    Ohyashiki K
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S56-8. PubMed ID: 15250023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of a combination treatment with cefodizime and minocycline for infections in patients complicated with hematological disorders].
    Hirakawa K; Tsuda S; Misawa S; Kuzuyama Y; Nakai H; Seriu T; Takashima T; Tanaka S; Nishigaki H; Yokota S
    Jpn J Antibiot; 1993 Aug; 46(8):686-96. PubMed ID: 8230736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
    Ito A; Maruta I; Ogawa K; Asada H; Matsuzaki M
    Jpn J Antibiot; 1985 Aug; 38(8):2108-18. PubMed ID: 4079002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.